AM 580
Rar agonist
Product Specifications
Background
AM-580, a benzoic derivative of retinoic acid and a selective RAR-α agonist, has been shown to significantly reduce the production of Th1 cytokines but promote Th2 cytokines in human PBMCs7 and to inhibit microglial activation, thus acting beneficially in Alzheimer's disease treatment. It also is known to inhibit tumor cell proliferation and induces apoptosis.
Product Name Alternative
4-[(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carboxamido]benzoic acid; CD336; NSC 608001; Ro 40-6055
UNSPSC
41116105
Source
Synthetic
Purity
>98% (HPLC) NMR (Conforms)
Weight
0.005
Format
Off-white powder
Solubility
May be dissolved in DMSO (35 mg/ml); or Ethanol (18 mg/ml)
Molecular Formula
C22H25NO3
Molecular Weight
351.4
Precautions
Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
References & Citations
1. Wang O., Thome R., Rostami A., Ma C-G., Zhang G-X. (2019) Nature. 16: 727-729. 2. Bosch A., et al. (2012) Breast Cancer Res. 14(4): R121.
CAS Number
102121-60-8
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6311253-01 0.1 mL
ITGB1BP1, ID (ITGB1BP1, ICAP1, Integrin beta-1-binding protein 1, Integrin cytoplasmic domain-associated protein 1) (MaxLight 550)
Ask
View Details 
MBS6311253-02 5x 0.1 mL
ITGB1BP1, ID (ITGB1BP1, ICAP1, Integrin beta-1-binding protein 1, Integrin cytoplasmic domain-associated protein 1) (MaxLight 550)
Ask
View Details